LABORATORIOS DEL DR. ESTEVE, S.A.;LABORATORIOS DEL DR. ESTEVE; S.A.;FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA - CAIXA;INSTITUCIO CATALANA DE RECERCA I ESTUDIS AVANCATS
The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including said immunogens.
